AbbVie Inc (BSP:ABBV34)
R$ 69.32 0 (0%) Market Cap: 1.97 Til Enterprise Value: 2.37 Til PE Ratio: 62.50 PB Ratio: 52.72 GF Score: 80/100

Q2 2022 Abbvie Inc Earnings Call Transcript

Jul 29, 2022 / 01:00PM GMT
Release Date Price: R$46.56 (-3.98%)
Operator

Good morning, and thank you for standing by. Welcome to the AbbVie Second Quarter 2022 Earnings Conference Call. (Operator Instructions) I'd now like to introduce Ms. Liz Shea, Vice President, Head of Investor Relations.

Elizabeth Shea
AbbVie Inc. - VP of IR

Good morning, and thanks for joining us. Also on the call with me today are Rick Gonzalez, Chairman of the Board and Chief Executive Officer; Rob Michael, Vice Chairman and President; Jeff Stewart, Executive Vice President, Chief Commercial Officer; and Tom Hudson, Senior Vice President, R&D and Chief Scientific Officer.

Joining us for the Q&A portion of the call are Laura Schumacher, Vice Chairman, External Affairs, Chief Legal Officer and Corporate Secretary; Carrie Strom, Senior Vice President and President of Global Allergan Aesthetics; Scott Brun, Senior Vice President and Chief Financial Officer; Neil Gallagher, Vice President, Development and Chief Medical Officer; and Roopal Thakkar, Vice President, Global Regulatory affairs. Before we get started, I'll note that some statements we

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot